Having trouble viewing this email? View in a browser.

You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.

Dermatology Times eNews

Dermatology Times eNews


February 1, 2012


FDA approves vismodegib for basal cell cancers

Washington — The Food and Drug Administration has approved the groundbreaking, first-in-class drug Erivedge (vismodegib, Genentech) to treat adult patients with advanced and metastatic basal cell cancers. » More

FDA OKs ingenol mebutate for AK treatment

Washington — The Food and Drug Administration has approved Picato gel (ingenol mebutate, Leo Pharma) as a treatment for actinic keratoses on the face, scalp, trunk and extremities. » More


No infection, environmental cause found for Morgellons

Atlanta — The Centers for Disease Control and Prevention has released a study that finds no evidence linking Morgellons disease to an infection or environmental cause. » More

FYI ...

2 million


Estimated number of Americans affected by basal cell carcinoma each year

Source: Skin Cancer Foundation


Pine bark extract improves skin aging signs

Dusseldorf, Germany — Clinical trial results suggest that natural supplement Pycnogenol (Horphag Research), an antioxidant plant extract from the bark of the French maritime pine tree, improves skin hydration and elasticity in women. » More


Find Resources to Help Manage Plaque Psoriasis Effectively


Ban baseball caps, Aussie cancer council urges

Sydney — The Cancer Council of New South Wales says baseball caps should be banned from schools because they place children at an unacceptable risk of developing skin cancers later in life, the Sydney Morning Herald reports. » More

New Job Opportunities

Center for Dermatology Care


Cynthia Dreyer MD

Dr. Ira Schlesinger


David A High MD

Dermatology Associates of Lancaster


Goldman Dermatology

Madison Skin & Laser


Manhattan Dermatology

Mark Burnett MD


Minden Dermatology

Ochsner Health System




Information Technology

Meetings & Events

Practice Management

Resource Centers


Follow us on Twitter

Digital Edition

View current edition

Powered by Modern Medicine Advanstar Medical Communications Group

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.